Literature DB >> 22331304

Human IgG directed against amphiphysin induces anxiety behavior in a rat model after intrathecal passive transfer.

Christian Geis1, Benedikt Grünewald, Andreas Weishaupt, Thomas Wultsch, Klaus V Toyka, Andreas Reif, Claudia Sommer.   

Abstract

Stiff person syndrome with auto-antibodies against amphiphysin is characterized by muscular stiffness, spasms, and anxiety which is a less appreciated core symptom. Here, we report that intrathecal application of purified immunoglobulin G-antibodies against amphiphysin from one patient induce anxiety behavior in rats. Immunostaining demonstrated binding of anti-amphiphysin antibodies to brain structures which are associated with anxiety disorders, such as the amygdala. We propose that antibody-mediated amphiphysin deficiency may account for anxiety behavior in stiff person syndrome via presynaptic dysregulation of GABAergic pathways.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22331304     DOI: 10.1007/s00702-012-0773-3

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  18 in total

Review 1.  The immunological basis for treatment of stiff person syndrome.

Authors:  Trygve Holmøy; Christian Geis
Journal:  J Neuroimmunol       Date:  2010-10-12       Impact factor: 3.478

Review 2.  Autoantibodies associated with diseases of the CNS: new developments and future challenges.

Authors:  Angela Vincent; Christian G Bien; Sarosh R Irani; Patrick Waters
Journal:  Lancet Neurol       Date:  2011-08       Impact factor: 44.182

3.  Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies.

Authors:  M C Dalakas; M Li; M Fujii; D M Jacobowitz
Journal:  Neurology       Date:  2001-09-11       Impact factor: 9.910

4.  Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin.

Authors:  Claudia Sommer; Andreas Weishaupt; Jörg Brinkhoff; Lydia Biko; Carsten Wessig; Ralf Gold; Klaus V Toyka
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

5.  A neuropsychological assessment of phobias in patients with stiff person syndrome.

Authors:  Rezvan Ameli; Joseph Snow; Goran Rakocevic; Marinos C Dalakas
Journal:  Neurology       Date:  2005-06-14       Impact factor: 9.910

6.  Behavioural and expressional phenotyping of nitric oxide synthase-I knockdown animals.

Authors:  T Wultsch; S Chourbaji; S Fritzen; S Kittel; E Grünblatt; M Gerlach; L Gutknecht; F Chizat; G Golfier; A Schmitt; P Gass; K P Lesch; A Reif
Journal:  J Neural Transm Suppl       Date:  2007

7.  Chronic catheterization of the spinal subarachnoid space.

Authors:  T L Yaksh; T A Rudy
Journal:  Physiol Behav       Date:  1976-12

8.  Neuropathology and binding studies in anti-amphiphysin-associated stiff-person syndrome.

Authors:  C Wessig; R Klein; M F Schneider; K V Toyka; M Naumann; C Sommer
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

9.  Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer.

Authors:  F Folli; M Solimena; R Cofiell; M Austoni; G Tallini; G Fassetta; D Bates; N Cartlidge; G F Bottazzo; G Piccolo; P De Camilli
Journal:  N Engl J Med       Date:  1993-02-25       Impact factor: 91.245

10.  Decreased synaptic vesicle recycling efficiency and cognitive deficits in amphiphysin 1 knockout mice.

Authors:  Gilbert Di Paolo; Sethuraman Sankaranarayanan; Markus R Wenk; Laurie Daniell; Ezio Perucco; Barbara J Caldarone; Richard Flavell; Marina R Picciotto; Timothy A Ryan; Ottavio Cremona; Pietro De Camilli
Journal:  Neuron       Date:  2002-02-28       Impact factor: 17.173

View more
  12 in total

Review 1.  Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.

Authors:  Josep Dalmau; Christian Geis; Francesc Graus
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

2.  'Moonlighting' surface antigens: a paradigm for autoantibody pathogenicity in neurology?

Authors:  Sarosh R Irani
Journal:  Brain       Date:  2016-02       Impact factor: 13.501

3.  The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model.

Authors:  Christian Geis; Christian Ritter; Christoph Ruschil; Andreas Weishaupt; Benedikt Grünewald; Guido Stoll; Trygve Holmoy; Tatsuro Misu; Kazuo Fujihara; Bernhard Hemmer; Christine Stadelmann; Jeffrey L Bennett; Claudia Sommer; Klaus V Toyka
Journal:  Exp Neurol       Date:  2014-12-24       Impact factor: 5.330

Review 4.  Paraneoplastic neurological syndromes.

Authors:  Francesc Graus; Josep Dalmau
Journal:  Curr Opin Neurol       Date:  2012-12       Impact factor: 5.710

5.  Measuring spinal presynaptic inhibition in mice by dorsal root potential recording in vivo.

Authors:  Benedikt Grünewald; Christian Geis
Journal:  J Vis Exp       Date:  2014-03-29       Impact factor: 1.355

Review 6.  'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

7.  Interactions of Human Autoantibodies with Hippocampal GABAergic Synaptic Transmission - Analyzing Antibody-Induced Effects ex vivo.

Authors:  Holger Haselmann; Luise Röpke; Christian Werner; Albrecht Kunze; Christian Geis
Journal:  Front Neurol       Date:  2015-06-11       Impact factor: 4.003

8.  Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes.

Authors:  Alexander Carvajal-González; M Isabel Leite; Patrick Waters; Mark Woodhall; Ester Coutinho; Bettina Balint; Bethan Lang; Philippa Pettingill; Aisling Carr; Una-Marie Sheerin; Rayomand Press; Raomand Press; Michael P Lunn; Ming Lim; Paul Maddison; H-M Meinck; Wim Vandenberghe; Angela Vincent
Journal:  Brain       Date:  2014-06-20       Impact factor: 13.501

Review 9.  GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions.

Authors:  Popianna Tsiortou; Harry Alexopoulos; Marinos C Dalakas
Journal:  Ther Adv Neurol Disord       Date:  2021-03-30       Impact factor: 6.570

10.  Systemic delivery of human GlyR IgG antibody induces GlyR internalization into motor neurons of brainstem and spinal cord with motor dysfunction in mice.

Authors:  A Carvajal-González; L Jacobson; L Clover; M Wickremaratchi; S Shields; B Lang; A Vincent
Journal:  Neuropathol Appl Neurobiol       Date:  2020-09-28       Impact factor: 6.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.